Status:
WITHDRAWN
Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
Lead Sponsor:
University Hospital, Ghent
Conditions:
Renal Failure, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Comparison of the efficacy of dialysis by conventional dialysis versus Prometheus artificial hepatic system
Detailed Description
After inclusion, patients will be dialysed with low-flux artificial kidneys. 1 week of dialysis exists of 3 days of dialysis. In week 4, day 2, patients will be treated once with the Prometheus artifi...
Eligibility Criteria
Inclusion
- Stable patients
- At least 3 months on dialysis
- Arterio-venous fistula
Exclusion
- Diabetic patients
- Malignancies
- Acute illnesses
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00262353
Last Update
July 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000